id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-317566-6ch6na31	Epstein, Robert S.	Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors	2020-07-08		.txt	text/plain	4854	219	43	INTRODUCTION: Chemotherapy-induced myelosuppression (CIM) is one of the most common dose-limiting complications of cancer treatment, and is associated with a range of debilitating symptoms that can significantly impact patients' quality of life. Methods: An online survey was conducted of participants with breast, lung, or colorectal cancer who had received chemotherapy treatment within the past 12 months, and had experienced at least one episode of myelosuppression in the past year. Methods: An online survey was conducted of participants with breast, lung, or colorectal cancer who had received chemotherapy treatment within the past 12 months, and had experienced at least one episode of myelosuppression in the past year. Despite the use of chemotherapy dose reductions and delays, G(M)-CSF, ESA injections, and blood transfusions to address CIM, the findings of this survey suggest that the real-world impact of myelosuppression on patients is substantial, with almost all participants reporting a moderate or major impact on their lives.	./cache/cord-317566-6ch6na31.txt	./txt/cord-317566-6ch6na31.txt